Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab

Article in Clinical Lymphoma Myeloma & Leukemia (May 2024)

Application of interim PET-CT in first-line treatment decision-making for lymphoma

Article in Journal of Zhejiang University-SCIENCE B (October 2023)

Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature

Article in Frontiers in Immunology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.